Host sequences flanking the human T-cell leukemia virus type 1 provirus in vivo

被引:36
作者
Leclercq, I
Mortreux, F
Cavrois, M
Leroy, A
Gessain, A
Wain-Hobson, S
Wattel, E
机构
[1] Univ Lyon 1, Ctr Leon Berard, Unite Oncogenese Virale, CNRS,UMR 5537, F-69373 Lyon 08, France
[2] Inst Rech Canc Lille, INSERM, U524, Lille, France
[3] Ctr Oscar Lambret, Unite Oncogenese Virale, F-59020 Lille, France
[4] Inst Pasteur, Unite Epidemiol Virus Oncogenes, Paris, France
[5] Inst Pasteur, Unite Retrovirol Mol, Paris, France
[6] CHU Lille, Serv Malad Sang, F-59037 Lille, France
关键词
D O I
10.1128/JVI.74.5.2305-2312.2000
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human pathogenic retroviruses do not have common: loci of: integration. However, many factors, such as chromatin structure, transcriptional activity, DNA-protein interaction, CpG methylation, and nucleotide composition of the target sequence, may influence integration site selection. These features have been investigated by in vitro integration reactions or by infection of cell lines with recombinant retroviruses. Less is known about target choice for integration in vivo. The present study was conducted in order to assess the characteristics of cellular sequences targeted for human T-cell leukemia virus type 1 (HTLV-1) integration in vivo. Sequencing integration sites from greater than or equal to 200 proviruses (19 kb of sequence): isolated from 29 infected individuals revealed that HTLV-1 integration is not random at the level of the nucleotide sequence. The virus was found to integrate in A/T-rich regions with a weak consensus sequence at positions within and without of the hexameric repeat generated during integration. These features were not associated with a preference for integration near active regions or repeat elements of the host chromosomes. Most or all of the regions of the genome appear to be accessible to HTLV-1 integration. As with integration in vitro, integration specificity in vivo seems to be determined by local features rather than by the accessibility of specific regions.
引用
收藏
页码:2305 / 2312
页数:8
相关论文
共 53 条
[1]   Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[2]   THE GENBANK GENETIC SEQUENCE DATA-BANK [J].
BILOFSKY, HS ;
BURKS, C .
NUCLEIC ACIDS RESEARCH, 1988, 16 (05) :1861-1863
[3]   DBEST - DATABASE FOR EXPRESSED SEQUENCE TAGS [J].
BOGUSKI, MS ;
LOWE, TMJ ;
TOLSTOSHEV, CM .
NATURE GENETICS, 1993, 4 (04) :332-333
[4]   IN-VITRO INTEGRATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 CDNA INTO TARGETS CONTAINING PROTEIN-INDUCED BENDS [J].
BOR, YC ;
BUSHMAN, FD ;
ORGEL, LE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (22) :10334-10338
[5]   CONSISTENT ASSOCIATION BETWEEN SIGMA-ELEMENTS AND TRANSFER-RNA GENES IN YEAST [J].
BRODEUR, GM ;
SANDMEYER, SB ;
OLSON, MV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (11) :3292-3296
[6]   Chromosome structure and human immunodeficiency virus type 1 cDNA integration: Centromeric alphoid repeats are a disfavored target [J].
Carteau, S ;
Hoffmann, C ;
Bushman, F .
JOURNAL OF VIROLOGY, 1998, 72 (05) :4005-4014
[7]  
Cavrois M, 1996, ONCOGENE, V12, P2419
[8]   STOCHASTIC EVENTS IN THE AMPLIFICATION OF HTLV-I INTEGRATION SITES BY LINKER-MEDIATED PCR [J].
CAVROIS, M ;
WAINHOBSON, S ;
WATTEL, E .
RESEARCH IN VIROLOGY, 1995, 146 (03) :179-184
[9]   Persistent oligoclonal expansion of human T-cell leukemia virus type 1 infected circulating cells in patients with Tropical spastic paraparesis HTLV-1 associated myelopathy [J].
Cavrois, M ;
Leclercq, I ;
Gout, O ;
Gessain, A ;
Wain-Hobson, S ;
Wattel, E .
ONCOGENE, 1998, 17 (01) :77-82
[10]   Adult T-cell leukemia/lymphoma on a background of clonally expanding human T-cell leukemia virus type-1-positive cells [J].
Cavrois, M ;
WainHobson, S ;
Gessain, A ;
Plumelle, Y ;
Wattel, E .
BLOOD, 1996, 88 (12) :4646-4650